Lead Story Picture

DaVita Finalizes $389M Settlement Over Kickback Claims

Dialysis giant DaVita HealthCare Partners Inc. has finalized a deal in which it will pay $389 million and unwind 11 joint ventures to resolve criminal and civil claims by a whistleblower that it provided kickbacks to kidney doctors, DaVita and the U.S. Department of Justice said Wednesday.

  • Brazilian Bidders Again Boost Chiquita Bid As Vote Nears

    The Brazilian suitors seeking to upend a $500 million-plus inversion between Chiquita Brands International Inc. and Ireland's Fyffes PLC again sweetened their own all-cash takeover offer for Chiquita on Thursday, a last-ditch effort to win shareholders' support before a Friday vote.

  • Jury Clears Apple In $94M Patent Suit Over IPhones, IPads

    Apple Inc. triumphed in GPNE Corp.'s $94 million patent trial Wednesday when a California federal jury unanimously found that the tech titan's iPhones and iPads didn't infringe two data-communications patents, though Apple failed to convince jurors that those patents are invalid.

  • Fifth Street Pulls Plug On IPO Amid Market Volatility

    Fifth Street Asset Management Inc. called off its plans Wednesday to raise nearly $240 million in an initial public offering, citing bumpy market conditions and continued volatility for new issuers.

  • BGC Partners Goes Hostile With $675M Bid for GFI Group

    BGC Partners Inc. said Wednesday it has launched a $675 million hostile takeover bid on for rival brokerage and trade services provider GFI Group Inc. after talks between the companies failed to result in a deal.

  • Mylan Signals $5.3B Abbott Inversion On Track After Tweaks

    Mylan Inc. and Abbott Laboratories said Wednesday that new limitations imposed by the Obama administration on tax-motivated M&A wouldn't derail their planned $5.3 billion inversion deal, though they did modify the terms of the transaction.